| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/07/2009 | WO2009023160A3 Novel inhibitors of bacterial sortase enzymes and methods of using the same |
| 05/07/2009 | WO2009021957A3 Tricyclic heterocyclic compounds as gaba a modulators |
| 05/07/2009 | WO2009021081A3 Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin |
| 05/07/2009 | WO2009020603A9 Upp amphiphilic alpha-helix mimetics |
| 05/07/2009 | WO2009018132A3 Methods and systems for attenuating the tolerance response to a drug |
| 05/07/2009 | WO2009018065A3 Novel glucokinase activators and methods of using same |
| 05/07/2009 | WO2009017701A3 Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment |
| 05/07/2009 | WO2009017463A3 NOVEL β-GLUCANS ISOLATED FROM HIGHER BASIDIOMYCETES MUSHROOM GANODERMA TSUGAE VAR. JANNIEAE |
| 05/07/2009 | WO2009016536A3 Preservative compositions for moist wipes |
| 05/07/2009 | WO2009013723A3 Ethyl pyruvate alone or in combination with mi cro- clustered water and use of the same |
| 05/07/2009 | WO2009012357A3 Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof |
| 05/07/2009 | WO2009011412A3 Combination of ampa receptor antagonists and acetylcholinesterase inhibitors for the treatment of neuropathic pain |
| 05/07/2009 | WO2009010789A3 Pyrimidine derivatives 934 |
| 05/07/2009 | WO2009007409A3 Oil in water emulsion comprising nsaids and quaternary ammonium halides |
| 05/07/2009 | WO2009006590A9 Docetaxel process and polymorphs |
| 05/07/2009 | WO2009006389A3 Pyrimidine derivatives useful as raf kinase inhibitors |
| 05/07/2009 | WO2008157179A3 N-substituted azaindoles and methods of use |
| 05/07/2009 | WO2008156828A3 Renin inhibitors |
| 05/07/2009 | WO2008155081A3 Substituted aromatic heterocyclic compounds as fungicides |
| 05/07/2009 | WO2008155035A3 Oxazolidinones for the treatment and prophylaxis of sepsis |
| 05/07/2009 | WO2008153792A3 Gamma secretase modulators |
| 05/07/2009 | WO2008153730A3 Method for treating proliferative disorders associated with mutations in c-met |
| 05/07/2009 | WO2008152068A3 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases |
| 05/07/2009 | WO2008148573A3 Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms |
| 05/07/2009 | WO2008140577A3 Cd44 pathway antagonists for treatment of adenoviral infection |
| 05/07/2009 | WO2008138126A8 Bicyclic pyrimidine derivatives as calcium channel blockers |
| 05/07/2009 | WO2008137761A3 Rna interference mediated inhibition of cyclic nucleotide type 4 phosphodiesterase (pde4b) gene expression using short interfering nucleic acid (sina) |
| 05/07/2009 | WO2008132234A3 Rna antagonist compounds for the modulation of beta-catenin |
| 05/07/2009 | WO2008129517A3 A stabilized delayed release pharmaceutical composition of rabeprazole |
| 05/07/2009 | WO2008127682A3 Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor |
| 05/07/2009 | WO2008124128A3 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders |
| 05/07/2009 | WO2008122858A3 Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals |
| 05/07/2009 | WO2008115263A3 Raf kinase inhibitors containing a zinc binding moiety |
| 05/07/2009 | WO2008112647A3 Nitroxide radical as a treatment for neurodegeneration |
| 05/07/2009 | WO2008109520A4 Nucleic acid compounds for inhibiting cxc gene expression and uses thereof |
| 05/07/2009 | WO2008108958A3 Benzimidazole derivatives and methods of use thereof |
| 05/07/2009 | WO2008106979A3 Pharmaceutical compositions comprising flavonoids and xylitol |
| 05/07/2009 | WO2008103314A3 Methods for modulating bone formation and mineralization |
| 05/07/2009 | WO2008098995A3 Genes involved in mitochondrial biogenesis |
| 05/07/2009 | WO2008095040A3 2-5a derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents |
| 05/07/2009 | WO2008077555A3 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 05/07/2009 | WO2008076278A3 Methods of cancer treatment with igf1r inhibitors |
| 05/07/2009 | WO2008074749A9 Indazole derivatives as kinase inhibitors for the treatment of cancer |
| 05/07/2009 | WO2008066935A3 Crystalline forms of tigecycline and processes for preparation thereof |
| 05/07/2009 | WO2008063943A3 Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain |
| 05/07/2009 | WO2008050339A3 Combination of an aminoglycoside antibiotic and a parp inhibitor |
| 05/07/2009 | WO2008049856A3 Methods of treating pain using cdk inhibitors |
| 05/07/2009 | WO2008045817A8 Compositions for reducing nicotine withdrawal symptoms and/or tobacco usage |
| 05/07/2009 | WO2008045664A3 Heterocyclic pde4 inhibitors as antiinflammatory agents |
| 05/07/2009 | WO2008039052A8 Process for stabilizing famotidine |
| 05/07/2009 | WO2008036353A3 Omega-3 diglyceride emulsions |
| 05/07/2009 | WO2008036294A3 Nos inhibitors for treatment of motor deficit disorders |
| 05/07/2009 | WO2008018085A3 Compositions and methods for treating dermatological abscesses |
| 05/07/2009 | WO2008017491A8 Ligustilide derivatives for the treatment of disorders of the central nervous system |
| 05/07/2009 | WO2008004223A3 Compounds and methods for the treatment of menopause and bone related disorders |
| 05/07/2009 | WO2007136988A3 Compounds and methods for modulating expression of gccr |
| 05/07/2009 | WO2007134161A8 Compositions and methods for inhibiting expression of the pcsk9 gene |
| 05/07/2009 | WO2007122400A9 Novel polypeptides and use thereof |
| 05/07/2009 | WO2007094827A3 All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization |
| 05/07/2009 | WO2007085933A3 Process for the preparation of n-[1-(s)-ethoxycarbonyl-1-butyl]-(s)-alanine-dmt complex and its use in the preparation of perindopril |
| 05/07/2009 | WO2007075572A3 Orally active purine-based inhibitors of heat shock protein 90 |
| 05/07/2009 | WO2007070173A3 Cetp inhibitors |
| 05/07/2009 | WO2007067364A3 Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs |
| 05/07/2009 | WO2007062028A3 Treatment of qt interval prolongation and diseases associated therewith |
| 05/07/2009 | WO2007059226A3 Photoactivatable antimicrobial agents |
| 05/07/2009 | WO2007059145A3 Process for metabolic control and high solute clearance and solutions for use therein |
| 05/07/2009 | WO2007044804A3 Piperidine derivatives and methods of use |
| 05/07/2009 | WO2007044726A3 Methods for reducing platelet activation and for the treatment of thrombotic events |
| 05/07/2009 | WO2007041453A3 Methods and compositions for treating cancer |
| 05/07/2009 | WO2007015262A3 A process for the preparation of (-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl)]piperidine |
| 05/07/2009 | WO2006133446A3 Treatment of cns disorders associated with mutations in genes encoding lysosomal enzymes |
| 05/07/2009 | WO2006133098A3 Pharmacological chaperones for treating obesity |
| 05/07/2009 | WO2006130832A3 Anti-infective and immunomodulatory compounds |
| 05/07/2009 | WO2006127678A3 Inhibition of p38 mark for treatment of obesity |
| 05/07/2009 | WO2006123355A3 Novel statin derivatives |
| 05/07/2009 | WO2006113242A3 Method of increasing testosterone and related steroid concentrations in women |
| 05/07/2009 | WO2006080022A3 Mri contrast agents for diagnosis and prognosis of tumors |
| 05/07/2009 | WO2006047277A3 Inhibitors of c-fms kinase |
| 05/07/2009 | WO2006027798A3 A process for preparation of an antidepressant compound |
| 05/07/2009 | WO2006020727A3 Methods for treating cns disorders by administration of agents to the nasal cavity |
| 05/07/2009 | US20090118702 Treatment Medium Delivery Device and Methods for Delivery of Such Treatment Mediums to the Eye Using such a Delivery Device |
| 05/07/2009 | US20090118685 Medicated sleeve |
| 05/07/2009 | US20090118660 Apparatus and method for in-vivo plasmapheresis using periodic backlush containing anticoagulant |
| 05/07/2009 | US20090118513 Chemical Compounds |
| 05/07/2009 | US20090118502 organic or inorganic salt of N-{3-[4'-(4-Aminomethyl-[1,2,3]triazol-1-ylmethyl)-2-fluoro-biphenyl- 4-yl]-2-oxo-oxazolidin-5-(S)-ylmethyl}-acetamide; anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents |
| 05/07/2009 | US20090118499 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors |
| 05/07/2009 | US20090118379 Saponifying a Marigold flower extract of esterified xanthophylls using a quaternary ammonium base such as benzyltriethylammonium hydroxide; saponifying extract by sodium hydroxide and ethanol; isomerizing lutein to zeaxanthin; food additives; nutrients; efficiency; medicine for cancer, heart, eyes |
| 05/07/2009 | US20090118378 Technical information for a formula of a natural facial moisturizing cream for daytime use which contains a propylene glycol extract of plant specie solanum tuberosum |
| 05/07/2009 | US20090118377 Apogossypolone and the uses thereof |
| 05/07/2009 | US20090118376 Memantine Protects Inflammation-Related Degeneration of Dopamine Neurons Through Inhibition of Over-Activated Microglia and Release of Neurotrophic Factors from Astroglia |
| 05/07/2009 | US20090118374 Sulfonamido compounds that antagonise the vanilloid trpv1 receptor |
| 05/07/2009 | US20090118373 Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops |
| 05/07/2009 | US20090118372 Inhibitors Of Biotin Protein Ligase |
| 05/07/2009 | US20090118371 Delta 6 Desaturase From Thraustochytrid and its Uses Thereof |
| 05/07/2009 | US20090118370 Method of treating cancer using dichloroacetate |
| 05/07/2009 | US20090118369 Use of CIS-9, Trans-11 Isomer of Conjugated Lineoleic Acid |
| 05/07/2009 | US20090118368 Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof |
| 05/07/2009 | US20090118366 Organic compounds |
| 05/07/2009 | US20090118365 Use of Prodrugs of GABA B Agonists for Treating Neuropathic and Musculoskeletal Pain |
| 05/07/2009 | US20090118364 Novel diterpenes from the fruiting body of antrodia camphorata and pharmaceutical compositions thereof |